Cargando…

Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice

Objective To evaluate the continuation rates of the 52-mg levonorgestrel-releasing intrauterine system (LNG-IUS) during the first 5 years of use, reasons for its discontinuation, bleeding patterns, and new contraceptive choice after the 5 (th) year, in adolescents and young women. Methods The pres...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Oliveira, Elaine Cristina Fontes, Rocha, Ana Luiza Lunardi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda. 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686754/ https://www.ncbi.nlm.nih.gov/pubmed/38029767 http://dx.doi.org/10.1055/s-0043-1776032

Ejemplares similares

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System
por: Teal, Stephanie B., et al.
Publicado: (2019)

Use of naproxen versus intracervical block for pain control during the 52-mg levonorgestrel-releasing intrauterine system insertion in young women: a multivariate analysis of a randomized controlled trial
por: de Oliveira, Elaine Cristina Fontes, et al.
Publicado: (2021)

Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device
por: Creinin, Mitchell D., et al.
Publicado: (2023)

Non-contraceptive applications of the levonorgestrel intrauterine system
por: Rodriguez, Maria Isabel, et al.
Publicado: (2010)

Role of the levonorgestrel intrauterine system in effective contraception
por: Attia, Abdelhamid M, et al.
Publicado: (2013)

Consecutive Use of the 52 mg Levonorgestrel-releasing Intrauterine System: Variations in Bleeding Patterns
por: Wittmann, Barbara Zantut, et al.
Publicado: (2020)

The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive
por: Jacobstein, Roy, et al.
Publicado: (2015)

Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling
por: Costescu, Dustin J
Publicado: (2016)

Levonorgestrel-Releasing Intrauterine System as a Contraceptive Method in Nulliparous Women: A Systematic Review
por: Zgliczynska, Magdalena, et al.
Publicado: (2020)

Continuation Rates of the 52-mg Levonorgestrel-releasing Intrauterine System according to the Primary Reason for its Use
por: Miranda, Laura, et al.
Publicado: (2021)

More than just contraception: the impact of the levonorgestrel-releasing intrauterine system on public health over 30 years
por: Gemzell-Danielsson, Kristina, et al.
Publicado: (2021)

Cost‐effectiveness analysis of a low‐dose contraceptive levonorgestrel intrauterine system in Sweden
por: Henry, Nathaniel, et al.
Publicado: (2015)

Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding
por: Beelen, Pleun, et al.
Publicado: (2021)

Effect of modified levonorgestrel‐releasing intrauterine system in human adenomyosis with heavy menstrual bleeding
por: Yang, Hong, et al.
Publicado: (2021)

Models and methods to characterise levonorgestrel release from intradermally administered contraceptives
por: Al Dalaty, Adnan, et al.
Publicado: (2021)

Exploring the Role of Levonorgestrel Intrauterine System (LNG-IUS) as a Method of Emergency Contraception (EC)
por: Kumari, Snigdha, et al.
Publicado: (2022)

Levonorgestrel release rates measured through analysis of two-rod contraceptive explants
por: Fuchs, Rachael, et al.
Publicado: (2020)

Expanding choice and access in contraception: an assessment of intrauterine contraception policies in low and middle-income countries
por: Ali, Moazzam, et al.
Publicado: (2019)

Is 2-dimensional transvaginal ultrasonography necessary 6 weeks after insertion of the levonorgestrel 52-mg intrauterine device?
por: van der Heijden, Patty A.H.H., et al.
Publicado: (2022)

Levonorgestrel intrauterine system: Current role in management of heavy menstrual bleeding
por: Magon, Navneet, et al.
Publicado: (2013)

Observational study of feasibility and acceptability of the levonorgestrel-releasing intrauterine device as a long-acting reversible contraceptive in a primary care setting in India
por: Iyengar, Sharad, et al.
Publicado: (2022)

Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization
por: Rajput, Amarjitsing, et al.
Publicado: (2022)

Association between knowledge about levonorgestrel emergency contraception and the risk of ectopic pregnancy following levonorgestrel emergency contraception failure: a comparative survey
por: Zhang, Duo, et al.
Publicado: (2016)

Case of rupture ectopic pregnancy with emergency contraception levonorgestrel 0.075 mg in a lactating woman
por: Masud, Nazish, et al.
Publicado: (2021)

The myth of menstruation: how menstrual regulation and suppression impact contraceptive choice
por: DeMaria, Andrea L., et al.
Publicado: (2019)

Levonorgestrel-releasing intrauterine system for treatment of heavy menstrual bleeding in adolescents with Glanzmann’s Thrombasthenia: illustrated case series
por: Lu, Meiqiu, et al.
Publicado: (2018)

Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling
por: Ali, Moazzam, et al.
Publicado: (2017)

Effects of the levonorgestrel-containing intrauterine device, copper intrauterine device, and levonorgestrel-containing oral contraceptive on susceptibility of immune cells from cervix, endometrium and blood to HIV-1 fusion measured ex vivo
por: Cavrois, Marielle, et al.
Publicado: (2019)

The New Extended-Cycle Levonorgestrel-Ethinyl Estradiol Oral Contraceptives
por: Bonnema, Rachel A., et al.
Publicado: (2011)

Over-The-Counter Availability of Levonorgestrel Emergency Contraception in Pharmacies on Oahu
por: Chin, Jennifer, et al.
Publicado: (2020)

Levonorgestrel-Releasing Intrauterine System and Iron Overload Syndrome
por: Vieira da Motta, Marcia, et al.
Publicado: (2013)

Levonorgestrel-Releasing Intrauterine System Use in Perimenopausal Women
por: Joo, Jong-Kil, et al.
Publicado: (2021)

Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis
por: Roberts, T E, et al.
Publicado: (2011)

Corrigendum to “Rowe P et al. safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A” [Contraception 2016;93:498–506]
por: Rowe, Patrick, et al.
Publicado: (2016)

An Accelerated Release Study to Evaluate Long-Acting Contraceptive Levonorgestrel-Containing in Situ Forming Depot Systems
por: Janagam, Dileep R., et al.
Publicado: (2016)

Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial
por: Whitaker, Lucy H.R., et al.
Publicado: (2023)

Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant
por: Ali, Moazzam, et al.
Publicado: (2016)

Gonadotropin Glycoforms Circulating in Women Using Progestins of the Levonorgestrel Family for Contraception
por: Eriksson, Karin, et al.
Publicado: (2020)

Levonorgestrel emergency contraception and bodyweight: are current recommendations consistent with historic data?
por: Kardos, László
Publicado: (2020)

An interactive website for informed contraception choice: randomised evaluation of Contraception Choices
por: Stephenson, Judith, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ajvh2n21p640h8srnjd7nhmrd1